Fig. 1.
Effects of WSBCW on gastrointestinal health in normal situation. (A) Whole gut transit after one-week pretreatment, (B) small intestine motility of mice after two-week pretreatment, and (C) small intestinal permeability as measured by FL intensity of FITC-dextran permeated into the serum of mice. Within each panel, values with “*” are significantly different from that of the control; *p < 0.05, **p < 0.01, ***p < 0.001.